Intravesical Disitamab Vedotin (RC48) for HER2‐Expressing High‐Risk Non‐Muscle‐Invasive Bladder Cancer: A Single‐Arm, Dose–Escalation Phase I Trial Study by Xu Chen, Ming Huang, Zehua Chen, Chengjunyu Zhang, Bolin Pan, Chu Liu, Wentong Xu, Jianmin Fang, Jian Huang, Tianxin Lin

Get full text

Comparison of Clinical Characteristics, Therapy, and Short-Term Prognosis between Blunt and Penetrating Abdominal Trauma: A Multicentric Retrospective Cohort Study by Yi Liu, Yunhe Gao, Zhida Chen, Jianxin Cui, Wenquan Liang, Ze Wang, Linde Sun, Chuan Pang, Yuan Lv, Guoxiao Liu, Tingting Lu, Gan Zhang, Xiaoyu Dong, Hong Xu, Sheng Yao, Feng Liang, Gang Liu, Gang Chen, Jianmiao He, Wentong Xu, Bo Wei, Hongqing Xi, Lin Chen

Get full text

Machine learning-based fusion model for predicting HER2 expression in breast cancer by Sonazoid-enhanced ultrasound: a multicenter study by Huiting Zhang, Manlin Lang, Huiming Shen, Hang Li, Ning Yang, Bo Chen, Yixu Chen, Hong Ding, Weiping Yang, Xiaohui Ji, Ping Zhou, Ligang Cui, Jiandong Wang, Wentong Xu, Xiuqin Ye, Zhixing Liu, Yu Yang, Tianci Wei, Hui Wang, Yuanyuan Yan, Changjun Wu, Yiyun Wu, Jingwen Shi, Yaxi Wang, Xiuxia Fang, Ran Li, Ping Liang, Jie Yu

Get full text